Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide for tympanic membrane retraction during ear surgery
ACTRN12617001385336Phase 3Withdrawn
- Sponsor
- Townsville University Hospital
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of nitrous oxide in Tympanic Membrane Retraction (2 arms), sponsored by Townsville University Hospital. Primary endpoint: Change in tympanic membrane retraction grade. Planned start Feb 2018; status: withdrawn.
02
Drugs
nitrous oxide
03
Conditions
Tympanic Membrane Retraction
Beyond the preview
Go deeper on ACTRN12617001385336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001385336.